These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17514806)

  • 21. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing the right intravesical chemotherapeutic agent. Results of an in vitro monolayer cell culture assay.
    Whelan P; Flynn C; Ramsden C
    Br J Urol; 1984 Dec; 56(6):655-7. PubMed ID: 6442872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absorption of doxorubicin and mitomycin C in perioperative instillation. An experimental and clinical study.
    Jauhiainen K; Eksborg S; Kangas L; Perilä M; Alfthan O
    Eur Urol; 1985; 11(4):269-72. PubMed ID: 3930252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 25. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
    Schwarzman MI; Johanson KE; Surya B; Brown J
    Urology; 1988 Oct; 32(4):335-8. PubMed ID: 3140465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U; Höbarth K
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 29. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 30. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
    Friedell GH
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S13-5. PubMed ID: 6416697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
    Maier U; Baumgartner G
    J Urol; 1989 Mar; 141(3):529-30. PubMed ID: 2493098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO; Giuliano F
    Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of mitomycin C on superficial bladder cancer.
    Soloway MS; Murphy WM; DeFuria MD; Crooke S; Finebaum P
    J Urol; 1981 May; 125(5):646-8. PubMed ID: 6785454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
    Okajima E; Motomiya Y; Ishuin M; Ikuma S; Ohara S
    Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
    [No Abstract]   [Full Text] [Related]  

  • 36. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].
    Jacobi GH; Engelmann U; Frohneberg D; Thüroff JW
    Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients.
    Huland H; Otto U
    Eur Urol; 1983; 9(2):84-6. PubMed ID: 6343089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer.
    Huland H; Otto U
    Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group.
    Malmström PU; Wijkström H; Lundholm C; Wester K; Busch C; Norlén BJ
    J Urol; 1999 Apr; 161(4):1124-7. PubMed ID: 10081852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.